Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation TVT 2022

What's best for my patient when it comes to their post-implant drug regimen?

Presenter: Megan Coylewright

June 10, 2022

Presentation TVT 2022

“Flight Plan” for LAAO: How to Not Suffer in Silence

Presenter: Megan Coylewright

June 09, 2022

Presentation TVT 2022

Comparative Effectiveness of Post-procedure Medications Following Left Atrial Appendage Occlusion: A DAPT Analysis With WATCHMAN FLX

Presenter: Megan Coylewright

June 09, 2022

Presentation TVT 2022

Shared Decision-making: How Should the Heart Team Approach PMR Patients in the Gray Zone of Risk and Anatomy?

Presenter: Megan Coylewright

June 08, 2022

Presentation TVT 2021

What Are the New LAAO Devices and What Problems Are They Solving

Presenter: Megan Coylewright

July 22, 2021

Presentation TVT 2021

PFO Closure for Stroke: When Should We Consider Patients Over 60 Years of Age?

Presenter: Megan Coylewright

July 22, 2021

Presentation TVT 2021

Pre-Procedural and Implant Guidance

Presenter: Megan Coylewright

July 21, 2021

Presentation TVT 2021

Shared Decision Making for the Management of the TAVR Patient

Presenter: Megan Coylewright

July 20, 2021

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

Presentation TVT 2019

Practicalities of Shared Decision-Making for Stroke Prevention: Relevance to LAA Occlusion and PFO Closure

Presenter: Megan Coylewright

June 14, 2019

Presentation TVT 2016

TVT 1071: Reduction of Left Ventricular Outflow Gradient in the Context of Septal Hypertrophy With Transcatheter Mitral Valve Repair

Presenter: Megan Coylewright, MD

June 16, 2016

Presentation TVT 2014

Transcatheter Mitral Valve-in-Ring

Presenter: Megan Coylewright

June 05, 2014

Advertisement

What's best for my patient when it comes to their post-implant drug regimen?

“Flight Plan” for LAAO: How to Not Suffer in Silence

Comparative Effectiveness of Post-procedure Medications Following Left Atrial Appendage Occlusion: A DAPT Analysis With WATCHMAN FLX

Shared Decision-making: How Should the Heart Team Approach PMR Patients in the Gray Zone of Risk and Anatomy?

What Are the New LAAO Devices and What Problems Are They Solving

PFO Closure for Stroke: When Should We Consider Patients Over 60 Years of Age?

Pre-Procedural and Implant Guidance

Shared Decision Making for the Management of the TAVR Patient

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Practicalities of Shared Decision-Making for Stroke Prevention: Relevance to LAA Occlusion and PFO Closure

TVT 1071: Reduction of Left Ventricular Outflow Gradient in the Context of Septal Hypertrophy With Transcatheter Mitral Valve Repair

Transcatheter Mitral Valve-in-Ring

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content